BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20191885)

  • 1. [Glaucoma--neurodegenerative disease].
    Tataru LC; Bogdănici CM
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1120-5. PubMed ID: 20191885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucoma as a neurodegenerative disease.
    Gupta N; Yücel YH
    Curr Opin Ophthalmol; 2007 Mar; 18(2):110-4. PubMed ID: 17301611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tendencies in the etiopathogenesis of glaucoma--present and future].
    Călugăru D; Călugăru M
    Oftalmologia; 2008; 52(3):10-22. PubMed ID: 19149112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of neuroprotection and rationale as a therapy for glaucoma.
    Levin LA; Peeples P
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S11-4. PubMed ID: 18284310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma.
    Martus P; Stroux A; Budde WM; Mardin CY; Korth M; Jonas JB
    Am J Ophthalmol; 2005 Jun; 139(6):999-1009. PubMed ID: 15953429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders?
    Haefliger IO; Fleischhauer JC; Flammer J
    Eye (Lond); 2000 Jun; 14 ( Pt 3B)():464-72. PubMed ID: 11026975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):353-5. PubMed ID: 18260297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
    Osborne NN
    Prog Brain Res; 2008; 173():339-52. PubMed ID: 18929120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological evidence of early functional damage in glaucoma and ocular hypertension.
    North RV; Jones AL; Drasdo N; Wild JM; Morgan JE
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1216-22. PubMed ID: 19850843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glaucoma as primary optic neuropathy].
    Nicolae A; Stefan C
    Oftalmologia; 2001; 54(4):5-8. PubMed ID: 12035602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of optic nerve head topography and visual field in eyes with open-angle and angle-closure glaucoma.
    Boland MV; Zhang L; Broman AT; Jampel HD; Quigley HA
    Ophthalmology; 2008 Feb; 115(2):239-245.e2. PubMed ID: 18082888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of the progressive optic neuropathy of glaucoma.
    Levin LA
    Ophthalmol Clin North Am; 2005 Sep; 18(3):355-64, v. PubMed ID: 16054993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction in glaucoma.
    Resch H; Garhofer G; Fuchsjäger-Mayrl G; Hommer A; Schmetterer L
    Acta Ophthalmol; 2009 Feb; 87(1):4-12. PubMed ID: 18507728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The ophthalmoscopic characteristics of the optic disk and the retinal layer of nerve fibers of the retina in glaucoma].
    Kurysheva NI
    Vestn Oftalmol; 2005; 121(4):46-9. PubMed ID: 16223048
    [No Abstract]   [Full Text] [Related]  

  • 17. What changes can we expect in the brain of glaucoma patients?
    Gupta N; Yücel YH
    Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S122-6. PubMed ID: 17998036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphology of the optic papilla in glaucoma. II. Secondary chronic open angle glaucoma].
    Budde WM; Jonas JB
    Klin Monbl Augenheilkd; 1999 Oct; 215(4):221-7. PubMed ID: 10572883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation.
    Schwartz M; London A
    Prog Brain Res; 2008; 173():375-84. PubMed ID: 18929122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in optical coherence tomography for glaucoma.
    Chang R; Budenz DL
    Curr Opin Ophthalmol; 2008 Mar; 19(2):127-35. PubMed ID: 18301286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.